
zzso is an oral platinum analog with demonstrated activity in a range of zzso The current study was designed to evaluate the effect of varying degrees of zzso impairment on the safety and zzso zzso of zzso 

Patients with advanced solid tumors, zzso to standard therapies, were zzso The study included four zzso of patients with varying levels of zzso function, and eight patients per zzso Group 1 zzso zzso normal zzso zzso zzso zzso mild zzso impairment zzso clearance zzso zzso zzso zzso zzso moderate impairment zzso 30 to zzso zzso zzso zzso severe impairment zzso zzso zzso zzso was administered orally at 80 zzso on days zzso every 35 zzso 

A total of 32 patients were zzso 8 patients in each zzso function zzso Each group tolerated the dose of 80 zzso on days zzso every 35 days without the need for dose zzso The most common adverse events were fatigue zzso zzso zzso zzso zzso anorexia zzso zzso zzso vomiting zzso zzso zzso and zzso zzso There were no zzso toxic effects in any study zzso There was increased exposure to plasma platinum and plasma zzso platinum in patients with moderate to severe zzso zzso 

zzso zzso was altered in patients with zzso zzso However, a corresponding increase in zzso toxic effects was not zzso 

